Hemispherx Biopharma (HEB) Announces EPO to Grant Rugged dsRNA-Related Patent
Tweet Send to a Friend
Hemispherx Biopharma (NYSE: HEB) announced that it received formal notice on June 18, 2015, that the European Patent Office's Examining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
